Public Company News

SS&C Signs Agreement with Insignia Financial

WINDSOR, Conn., Dec. 10, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc.  (Nasdaq: SSNC) today announced an initial agreement with Insignia Financial (Insignia) to deliver superannuation member administration services. Insignia Financial supports around 1.1 million superannuation fund member...

2024-12-10 07:00 3564

Seoul National University Bundang Hospital Establishes the first "International PSP Research and Treatment Center" in Korea

* MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center * Tackling Global Challenges in an Aging Era… "Aspiring to become a global research and treatment hub for the rare neurodegenerative disease" SEOUL, South Korea, Dec. 9, 2024 /PRNe...

2024-12-09 22:00 3869

Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW

Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer d...

2024-12-09 22:00 3540

Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio

SHENZHEN, China, Dec. 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, new media and artificial intelligence (AI) solutions, today announced that it has signed a non-binding letter of intent to acquire 100% o...

2024-12-09 21:30 3805

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial

* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * Appoints US-based Chief Commercial Officer, Andrew Udell * Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media. SYDNEY, Dec. 9, 2024 /PRNewswire/ -- A...

2024-12-09 21:00 3482

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

BEIJING, Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that the National Medical Products Administration of...

2024-12-09 20:30 3495

Noah Showcases Global Expansion and Investment Product Leadership at 2024 Corporate Open Day

* Accelerating global expansion into emerging markets with new brands * Global investment allocation strategies and expanded product offerings drive long-term value for clients * Expanding comprehensive service matrix to address evolving client needs globally SHANGHAI, Dec. 9, 2024 /PRNewswi...

2024-12-09 19:00 3542

Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting

DZD8586 demonstrated encouraging anti-tumor activity with manageable safety and favorable pharmacokinetic (PK) characteristics in patients with B-NHL SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment o...

2024-12-09 18:00 2725

LONGi and Raystech Announce Exclusive Strategic Partnership to Transform Australia's Solar Market

XI'AN, China, Dec. 9, 2024 /PRNewswire/ -- On November 25, Raystech Group Pty. Ltd. ("Raystech"), one ofAustralia's leading photovoltaic distributors, signed a groundbreaking strategic cooperation agreement with LONGi Green Energy Technology Co., Ltd. ("LONGi") at LONGi's headquarters inXi'an. ...

2024-12-09 17:19 3365

Warner Bros. Discovery and the Macao Tourism Office Announce Monumental Macao, Set to Premiere Across Multiple Countries and Regions

MACAO, Dec. 9, 2024 /PRNewswire/ -- Today, Warner Bros. Discovery and The Macao Government Tourism Office (MGTO) announced the release of the documentary MonumentalMacao. Produced in partnership with Discovery and Rolling Earth Pictures, and distributed by Discovery, Monumental Macao highlights th...

2024-12-09 17:18 3124

iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users

BEIJING, Dec. 9, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, recently launched a new 'Extra Large Font' function on its app, offering a comprehensive suite of accessibility features tailored for senior users and the visual requirements of a broader audience. With ju...

2024-12-09 17:05 3490

Acer Announces November Revenues at NT$22.75 Billion, Up 20.9% Month-on-month and 13.1% Year-on-year

TAIPEI, Dec. 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for November atNT$22.75 billion with 20.9% growth month-on-month and 13.1% growth year-on-year (YoY). Consolidated revenues for year-to-November revenues reachedNT$240.16 billion with 10.4% growth YoY....

2024-12-09 16:44 2540

Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2024

BEIJING, Dec. 9, 2024 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in mainlandChina's online social networking space, today announced its unaudited financial results for the third quarter of 2024.   Third Quarter of 2024 Highlights * Net r...

2024-12-09 16:16 3202

TrinaTracker unlocks its SuperTrack potential, with annual power generation increased 2% to 4%

CHANGZHOU, China, Dec. 9, 2024 /PRNewswire/ -- Three experts in the field of photovoltaics have taken an in-depth look at the prospects for the global application of solar trackers and the value and trends of intelligent tracking technology, and discussed the growth of intellectualization and dig...

2024-12-09 15:00 4145

TPIsoftware's Overseas Success Recognized with Global Banking & Finance Award®

TAIPEI, Dec. 9, 2024 /PRNewswire/ -- TPIsoftware (7781) has been honored with the Best Open Banking APIs Southern Asia 2024 award from the Global Banking & Finance Awards® in recognition of its proprietary enterprise API management platform digiRunner. Established by the UK-based leading financia...

2024-12-09 11:10 3152

2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting

SHANGHAI, Dec. 8, 2024 /PRNewswire/ -- December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versus-Host Disease (cGvHD) who have either progressed or not responded to one or mo...

2024-12-09 10:40 2975

MARRIOTT BONVOY'S MOST ANTICIPATED HOTELS & RESORTS OPENING ACROSS ASIA PACIFIC EXCLUDING CHINA IN 2025

SINGAPORE, Dec. 9, 2024 /PRNewswire/ -- Marriott Bonvoy is thrilled to announce a series of highly anticipated hotel openings acrossAsia Pacific excluding China in 2025. This exciting year will see the opening of three stunning JW Marriott Hotels & Resorts, the re-opening ofW Maldives, the debut ...

2024-12-09 10:30 8049

Agoda Celebrates International Mountain Day with Top 5 Mountain Destinations in Asia

SINGAPORE, Dec. 9, 2024 /PRNewswire/ -- In celebration of International Mountain Day onDecember 11, digital travel platform Agoda shares the top five mountain destinations acrossAsia based on Agoda's 2024 booking data. These destinations offer travelers unique experiences, from exploring volcanic...

2024-12-09 09:00 2868

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward  undruggable targets, today presented preliminary Phase I data of BET inhibitor JAB-8263 to treat myelofibrosis (MF) at the 2024 ASH (Ame...

2024-12-09 08:42 2601

Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for Advanced Lymphoma at the 66th ASH Annual Meeting

* CS5001 is so far the first anti-ROR1 ADC known to show clinical anti-tumor activity in both solid tumors and lymphomas. The data presented at ASH highlighted the latest safety and efficacy of CS5001 as a monotherapy for patients with advanced lymphomas. * CS5001 is well tolerated in heavily...

2024-12-09 08:20 4427